1. 2345 Neoadjuvant docetaxel, cisplatin, and 5-fluorouracil (dcf) compared to standard chemotherapy for resectable gastroesophageal adenocarcinoma. (September 2015) Authors: Kim, S.; Paget-Bailly, S.; Fiteni, F.; Messager, M.; Nguyen, T.; Mathieu, P.; Lamfichekh, N.; Fein, F.; Fratte, S.; Cleau, D.; Calcagno, F.; Lakkis, Z.; Jary, M.; Sakek, N.; Jacquin, M.; Foubert, A.; Bonnetain, F.; Mariette, C.; Borg, C. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S449 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Perioperative docetaxel, cisplatin, and 5-fluorouracil compared to standard chemotherapy for resectable gastroesophageal adenocarcinoma. Issue 1 (January 2017) Authors: Kim, S.; Paget-Bailly, S.; Messager, M.; Nguyen, T.; Mathieu, P.; Lamfichekh, N.; Fein, F.; Fratté, S.; Cléau, D.; Lakkis, Z.; Jary, M.; Sakek, N.; Jacquin, M.; Foubert, A.; Bonnetain, F.; Mariette, C.; Fiteni, F.; Borg, C. Journal: European journal of surgical oncology Issue: Volume 43:Issue 1(2017:Jan.) Page Start: 218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗